Search Result

Results for "

n-4-methoxy-3-5-dimethyl-2-pyridinyl-methyl-omeprazole-d3

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Apoptosis (11) Aryl Hydrocarbon Receptor (5) Atg8/LC3 (10) Autophagy (10) Bacterial (16) Biochemical Assay Reagents (3) Cholecystokinin Receptor (1) CRFR (2) Cytochrome P450 (16) Drug Derivative (5) Drug Intermediate (9) Drug Metabolite (14) Endogenous Metabolite (3) Environmental Pollutants (2) Exosomes (1) HBV (1) HSV (1) Interleukin Related (10) Isotope-Labeled Compounds (22) Keap1-Nrf2 (1) MMP (1) MOFs (17) Na+/K+ ATPase (10) Nucleoside Antimetabolite/Analog (1) Prolyl Endopeptidase (PREP) (1) PROTAC Linkers (2) Proton Pump (16) Reference Standards (12) TNF Receptor (10)
By Research Areas:	Cancer (22) Endocrinology (5) Infection (18) Inflammation/Immunology (13) Metabolic Disease (17) Neurological Disease (7)
Oligonucleotides:	Adenosine (1) Nucleoside Analogs (1)

100

Inhibitors & Agonists

Screening Libraries

Biochemical Assay Reagents

Peptides

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-B0113

*Omeprazole* Maximum Cited Publications 8 Publications Verification H 16868	Na+/K+ ATPase Proton Pump Bacterial Cytochrome P450 Apoptosis Autophagy Atg8/LC3 TNF Receptor Interleukin Related	Infection Neurological Disease Inflammation/Immunology Cancer
Omeprazole (H 16868) is an orally active H ⁺,K ⁺-ATPase inhibitor and a proton pump inhibitor. Omeprazole competitively inhibits CYP2C19, CYP3A4, and CYP2C9 activity. Omeprazole inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole inhibits pancreatic cancer cell proliferation, induces apoptosis, autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole aslo has neuroprotective and antibacterial effects .

HY-17021

Esomeprazole 3 Publications Verification (S)-omeprazole; (-)-omeprazole	Proton Pump Bacterial	Inflammation/Immunology Endocrinology Cancer
Esomeprazole ((S)-Omeprazole) is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H ⁺, K ⁺-ATPase in gastric parietal cells. Esomeprazole has the potential for symptomatic gastroesophageal reflux disease research .

HY-Y0808

Dimethyl succinate 1 Publications Verification	Environmental Pollutants Apoptosis	Neurological Disease Metabolic Disease
Dimethyl succinate is an orally active cell permeable succinate analogue. Dimethyl succinate can disrupt the TCA cycle by elevating intracellular succinate levels, leading to reduced protein synthesis and impairs myogenic differentiation. Dimethyl succinate can induce apoptosis. Dimethyl succinate can decrease maximal cellular respiration and reserve capacity. Dimethyl succinate can rescue synapse loss in AD. Dimethyl succinate can be used for the researches of metabolic and neurological disease ^[1][2].

HY-B0113A

Omeprazole sodium Maximum Cited Publications 8 Publications Verification H 16868 sodium	Na+/K+ ATPase Interleukin Related Proton Pump Cytochrome P450 Bacterial Apoptosis Autophagy TNF Receptor Atg8/LC3	Infection Inflammation/Immunology
Omeprazole (H 16868) sodium is an orally active H ⁺,K ⁺-ATPase inhibitor and a proton pump inhibitor. Omeprazole sodium competitively inhibits CYP2C19, CYP3A4, and CYP2C9 activity. Omeprazole sodium inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole sodium inhibits pancreatic cancer cell proliferation, induces apoptosis, autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole sodium alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole sodium aslo has neuroprotective and antibacterial effects .

HY-17023

Esomeprazole sodium 2 Publications Verification (S)-omeprazole sodium; (-)-omeprazole sodium	Exosomes Proton Pump Bacterial	Endocrinology Cancer
Esomeprazole sodium ((S)-Omeprazole sodium) is a potent and orally active proton pump inhibitor. Esomeprazole reduces acid secretion through inhibition of the H ⁺, K ⁺-ATPase in gastric parietal cells. Esomeprazole acts as an exosome inhibitor by blocking the exosome release via the inhibition of V-H ⁺-ATPases . Esomeprazole has the potential for symptomatic gastroesophageal reflux disease research .

HY-G0007

Omeprazole sulfone 2 Publications Verification omeprazole sulphone	Drug Metabolite Cytochrome P450 Aryl Hydrocarbon Receptor	Inflammation/Immunology
Omeprazole sulfone (Omeprazole sulphone) is one of the major circulating metabolites of Omeprazole (HY-B0113) in vivo, and belongs to class 4 non-mutagenic impurities. Omeprazole sulfone does not bind to the aryl hydrocarbon receptor (AhR), nor does it induce the expression of CYP1A1 or CYP1A2. However, Omeprazole sulfone promotes the migration of gastric epithelial cells under basal conditions and reverses the inhibitory effect of Indomethacin (HY-14397) on cell migration. Omeprazole sulfone does not promote cell proliferation, nor does it upregulate COX-2 expression or activate signaling pathways such as ERK, P38 MAPK and PI3K. Omeprazole sulfone maintains basal ulcer healing under non-acid-dependent conditions and can be used in studies related to gastric ulcer repair .

HY-P1108A

Astressin 2B TFA 1 Publications Verification	CRFR	Neurological Disease Inflammation/Immunology
Astressin 2B TFA is a blood-brain barrier-impermeable, highly selective CRFR2 antagonist (rCRFR2, IC₅₀=0.57 nM). Astressin 2B TFA blocks the protective effects mediated by CRFR2, thereby exacerbating indomethacin (HY-14397)-induced hemorrhagic intestinal injury in rats. Astressin 2B TFA reverses the protective effects of Urocortin 1 against intestinal hypermotility, bacterial invasion and upregulation of inflammatory mediators. Astressin 2B TFA also blocks the anxiogenic effect of Urocortin 2 and attenuates stress-induced anxiety-related behaviors. In the Clostridioides difficile toxin A (C. difficile toxin A)-mediated enteritis model, Astressin 2B TFA mimics the phenotype of CRFR2-deficient mice, significantly exacerbating intestinal epithelial damage, edema, neutrophil migration and the expression of multiple proinflammatory cytokines. Astressin 2B TFA is an important tool molecule for investigating the intestinal protective mechanisms of CRFR2 .

HY-P1108

Astressin 2B 1 Publications Verification	CRFR	Neurological Disease Inflammation/Immunology
Astressin 2B is a blood-brain barrier-impermeable, highly selective CRFR2 antagonist (rCRFR2, IC₅₀=0.57 nM). Astressin 2B blocks the protective effects mediated by CRFR2, thereby exacerbating indomethacin (HY-14397)-induced hemorrhagic intestinal injury in rats. Astressin 2B reverses the protective effects of Urocortin 1 against intestinal hypermotility, bacterial invasion and upregulation of inflammatory mediators. Astressin 2B also blocks the anxiogenic effect of Urocortin 2 and attenuates stress-induced anxiety-related behaviors. In the Clostridioides difficile toxin A (C. difficile toxin A)-mediated enteritis model, Astressin 2B mimics the phenotype of CRFR2-deficient mice, significantly exacerbating intestinal epithelial damage, edema, neutrophil migration and the expression of multiple proinflammatory cytokines. Astressin 2B is an important tool molecule for investigating the intestinal protective mechanisms of CRFR2 .

HY-G0006

Omeprazole sulfide 2 Publications Verification Ufiprazole	Drug Metabolite Aryl Hydrocarbon Receptor Bacterial	Infection Metabolic Disease
Omeprazole sulfide (Ufiprazole) is a metabolic degradation product of Omeprazole (HY-B0113). Omeprazole sulfide acts as a modulator of AhR. Omeprazole sulfide in cells with low CYP3A4 expression, functions as an AhR antagonist; however, in cells with high CYP3A4 expression, it is rapidly metabolized to Omeprazole, thereby acting as an AhR agonist. Omeprazole sulfide exhibits antibacterial activity when conjugated with silver nanoparticles (AgNPs). Omeprazole sulfide can be used in research on acid suppression and bacterial infections .

HY-76633

Dimethyl 4-hydroxyisophthalate	Drug Derivative	Others
Dimethyl 4-hydroxyisophthalate is a methyl salicylate analogue.

HY-126857

5-Hydroxyomeprazole Hydroxyomeprazole	Drug Metabolite	Inflammation/Immunology
5-Hydroxyomeprazole (Hydroxyomeprazole) is a major metabolite of Omeprazole (HY-B0113) through catalysis by CYP2C19 .

HY-W009082

Methyl behenate 1 Publications Verification methyl docosanoate	Biochemical Assay Reagents	Others
Methyl behenate (Methyl docosanoate) is a fatty acid methyl ester, can be found in the plant Aspidopterys obcordata Lemsl. Methyl behenate can be used as a phase change material .

HY-W004286

Methyl laurate methyl dodecanoate	Environmental Pollutants Drug Derivative	Others
Methyl laurate (Methyl dodecanoate) is a fatty acid methyl ester. Methyl laurate can serve as a raw material to produce sucrose monolaurate via transesterification with sucrose .

HY-B0113R

Omeprazole (Standard) H 16868 (Standard)	Reference Standards Na+/K+ ATPase Interleukin Related Proton Pump Cytochrome P450 Bacterial Apoptosis Autophagy TNF Receptor Atg8/LC3	Infection Metabolic Disease Cancer
Omeprazole (Standard) is the analytical standard of Omeprazole. This product is intended for research and analytical applications. Omeprazole (H 16868) is an orally active H ⁺,K ⁺-ATPase inhibitor and a proton pump inhibitor. Omeprazole competitively inhibits CYP2C19, CYP3A4, and CYP2C9 activity. Omeprazole inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole inhibits pancreatic cancer cell proliferation, induces apoptosis, autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole aslo has neuroprotective and antibacterial effects .

HY-17021B

Esomeprazole potassium salt 2 Publications Verification (S)-omeprazole potassium salt; (-)-omeprazole potassium salt	Proton Pump Bacterial	Inflammation/Immunology Endocrinology Cancer
Esomeprazole potassium salt ((S)-Omeprazole potassium salt) is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H ⁺, K ⁺-ATPase in gastric parietal cells. Esomeprazole potassium salt has the potential for symptomatic gastroesophageal reflux disease research .

HY-B0113S

Omeprazole-d3 1 Publications Verification H 16868-d₃	Na+/K+ ATPase Interleukin Related Proton Pump Cytochrome P450 Bacterial Apoptosis Autophagy TNF Receptor Atg8/LC3	Infection Metabolic Disease Cancer
Omeprazole-d₃ (H 16868-d₃) is deuterium labeled Omeprazole. Omeprazole (H 16868) is an orally active H ⁺,K ⁺-ATPase inhibitor and a proton pump inhibitor. Omeprazole competitively inhibits CYP2C19, CYP3A4, and CYP2C9 activity. Omeprazole inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole inhibits pancreatic cancer cell proliferation, induces apoptosis, autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole aslo has neuroprotective and antibacterial effects .

HY-P10143

MMP-2/MMP-9 Substrate Ac-Pro-Leu-Gly-[(S)-2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OEt	MMP	Others
MMP-2/MMP-9 Substrate (Ac-Pro-Leu-Gly-[(S)-2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OEt) is a synthetic chromogenic polypeptide substrate whose core structure mimics the cleavage sites of MMP-2 and MMP-9 (gelatinase A and B) in collagen. After being hydrolyzed by collagenase, MMP-2/MMP-9 Substrate reacts with 4,4'-dithiodipyridine or Ellman's Reagent via its thiol fragment to produce a product with ultraviolet absorption properties .

HY-109546

Omeprazole magnesium	Na+/K+ ATPase Interleukin Related Proton Pump Cytochrome P450 Bacterial Apoptosis Autophagy TNF Receptor Atg8/LC3	Infection Metabolic Disease Cancer
Omeprazole (H 16868) magnesium is an orally active H ⁺,K ⁺-ATPase inhibitor and a proton pump inhibitor. Omeprazole magnesium competitively inhibits CYP2C19, CYP3A4, and CYP2C9 activity. Omeprazole magnesium inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole magnesium inhibits pancreatic cancer cell proliferation, induces apoptosis, autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole magnesium alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole magnesium aslo has neuroprotective and antibacterial effects .

HY-W209628

Methyl 2-acetoxybenzoate methyl acetylsalicylate	Drug Intermediate	Inflammation/Immunology
Methyl 2-acetoxybenzoate (Methyl acetylsalicylate) is a safe and simple anti-inflammatory aspirin prodrug. Methyl 2-acetoxybenzoate (Methyl acetylsalicylate) can be chemical or enzymatically hydrolysed to methyl 2-hydroxy benzoate. Methyl 2-acetoxybenzoate (Methyl acetylsalicylate) can be used as analgesic agent in liniments and also inflammatory diseases research .

HY-129923

*(R)-Omeprazole* sodium**	Cytochrome P450	Neurological Disease
(R)-Omeprazole sodium is a gastric acid resistant compound with activity to inhibit gastric acid secretion. (R)-Omeprazole sodium is metabolized in vivo, and its metabolism is primarily affected by cytochrome P450 enzymes. The interaction between (R)-Omeprazole sodium and mannitol may affect its bioavailability in formulations. (R)-Omeprazole sodium exhibits reversible direct and metabolism-dependent inhibition of CYP2C19 .

HY-17021A

Esomeprazole magnesium salt (S)-omeprazole magnesium salt; (-)-omeprazole magnesium salt	Proton Pump Bacterial	Inflammation/Immunology Endocrinology Cancer
Esomeprazole magnesium salt ((S)-Omeprazole magnesium salt) is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H ⁺, K ⁺-ATPase in gastric parietal cells. Esomeprazole magnesium salt has the potential for symptomatic gastroesophageal reflux disease research .

HY-128454S

Dimethyl trisulfide-d6	Endogenous Metabolite	Others
Dimethyl trisulfide-d6 is deuterium labeled Dimethyl trisulfide (HY-128454). Dimethyl trisulfide is a cyanide antidote .

HY-W098612

Methyl N-(3-methoxy-3-oxopropyl)-N-methyl-beta-alaninate	PROTAC Linkers	Cancer
Methyl N-(3-methoxy-3-oxopropyl)-N-methyl-beta-alaninate is a PROTAC linker that can be used in the synthesis of PROTACs.

HY-P4308

*Z-Pro-Pro-aldehyde-dimethyl* acetal**	Prolyl Endopeptidase (PREP)	Neurological Disease
Z-Pro-Pro-aldehyde-dimethyl acetal is a potent inhibitor of prolyl endopeptidase (PREP), a cytoplasmic serine endoprotease (IC₅₀= 12 nM). Z-Pro-Pro-aldehyde-dimethyl acetal plays an important role in cognitive dysfunction in aging and neurodegenerative diseases including Alzheimer's disease .

HY-G0007R

Omeprazole sulfone (Standard) omeprazole sulphone (Standard)	Reference Standards Drug Metabolite Cytochrome P450 Aryl Hydrocarbon Receptor	Infection Cancer
Omeprazole sulfone (Standard) is the analytical standard of Omeprazole sulfone. This product is intended for research and analytical applications. Omeprazole sulfone (Omeprazole sulphone) is one of the major circulating metabolites of Omeprazole (HY-B0113) in vivo, and belongs to class 4 non-mutagenic impurities. Omeprazole sulfone does not bind to the aryl hydrocarbon receptor (AhR), nor does it induce the expression of CYP1A1 or CYP1A2. However, Omeprazole sulfone promotes the migration of gastric epithelial cells under basal conditions and reverses the inhibitory effect of Indomethacin (HY-14397) on cell migration. Omeprazole sulfone does not promote cell proliferation, nor does it upregulate COX-2 expression or activate signaling pathways such as ERK, P38 MAPK and PI3K. Omeprazole sulfone maintains basal ulcer healing under non-acid-dependent conditions and can be used in studies related to gastric ulcer repair .

HY-135111

4-Desmethoxy Omeprazole	Drug Metabolite	Infection Metabolic Disease Cancer
4-Desmethoxy Omeprazole is the active metabolite of Omeprazole. Omeprazole, a proton pump inhibitor (PPI), is available for treatment of acid-related gastrointestinal disorders. Omeprazole shows competitive inhibition of CYP2C19 activity with a K_i of 2 to 6 μM . Omeprazole also inhibits growth of Gram-positive and Gram-negative bacteria .

HY-Z2667

(R)-Esomeprazole (R)-omeprazole; (+)-omeprazole	Cytochrome P450	Metabolic Disease Inflammation/Immunology
(R)-Esomeprazole ((R)-Omeprazole; (+)-Omeprazole) is an orally active cytochrome P450 2C19, CYP3A4, and CYP2C9-related metabolic modulator. (R)-Esomeprazole can be used in studies of digestive system diseases and compound metabolic interactions .

HY-126857S

*5-Hydroxy Omeprazole-d3*	Isotope-Labeled Compounds Drug Metabolite	Others
5-Hydroxy Omeprazole-d₃ is deuterium labeled 5-Hydroxyomeprazole.

HY-W014347

Methyl 3-methoxy-4-nitrobenzoate	Drug Intermediate	Others
Methyl 3-methoxy-4-nitrobenzoate is a drug intermediate for synthesis of various active compounds.

HY-138199S

Omeprazole sulfone N-oxide-13C,d3	Isotope-Labeled Compounds	Others
Omeprazole sulfone N-oxide- ¹³C,d₃ is the deuterium and ¹³C labeled Omeprazole sulfone N-Oxide .

HY-W009082R

Methyl behenate (Standard) methyl docosanoate (Standard)	Reference Standards Biochemical Assay Reagents	Others
Methyl behenate (Standard) is the analytical standard of Methyl behenate (HY-W009082). This product is intended for research and analytical applications. Methyl behenate (Methyl docosanoate) is a fatty acid methyl ester. Methyl behenate can be isolated from the plant Aspidopterys obcordata Lemsl. Methyl behenate can be used as a phase change material .

HY-W003365

*(2-Chloro-4-pyridinyl)methanol*	Biochemical Assay Reagents	Others
(2-chloro-4-pyridinyl)methanol is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

HY-Z2338

5-O-Desmethyl omeprazole	Drug Metabolite	Others
5-O-Desmethyl omeprazole is a metabolite of Omeprazole by cytochrome P450 .

HY-W131494S

*(N)-Methyl* omeprazole-d3**	Isotope-Labeled Compounds	Others
(N)-Methyl omeprazole-d₃ is the deuterium labeled (N)-Methyl omeprazole .

HY-B0113S2

Omeprazole sulfone (methoxy-d3) omeprazole sulphone (methoxy-d₃)	Isotope-Labeled Compounds Na+/K+ ATPase Interleukin Related Proton Pump Cytochrome P450 Bacterial Apoptosis Autophagy TNF Receptor Atg8/LC3	Infection Cancer
Omeprazole sulfone (methoxy-d₃) is the deuterium labeled Omeprazole sulfone. Omeprazole sulfone (H 16868) is an orally active H ⁺,K ⁺-ATPase inhibitor and a proton pump inhibitor. Omeprazole sulfone competitively inhibits CYP2C19, CYP3A4, and CYP2C9 activity. Omeprazole sulfone inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole sulfone inhibits pancreatic cancer cell proliferation, induces apoptosis, autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole sulfone alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole sulfone aslo has neuroprotective and antibacterial effects .

HY-W777620

*1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone-13C,d3* rac-Cotinine-¹³C,d₃	Isotope-Labeled Compounds	Others
1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone- ¹³C,d₃ (rac-Cotinine- ¹³C,d₃) is the deuterium and ¹³C-labeled 1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone (HY-W588192).

HY-W011637

Methyl brassylate dimethyl tridecanedioate	Drug Derivative	Metabolic Disease
Methyl brassylate (Dimethyl tridecanedioate) is an ester product.

HY-W701567

Dimethyl (S)-(4-(methyl-d3)-2-oxooctyl)phosphonate	Isotope-Labeled Compounds	Others
Dimethyl (S)-(4-(methyl-d₃)-2-oxooctyl)phosphonate is the deuterium labeled Dimethyl (S)-(4-(methyl)-2-oxooctyl)phosphonate.

HY-N13837

*2-Methoxy-1,6-dimethyl-5-vinyl-9,10-dihydrophenanthren-7-ol*	Drug Derivative HSV	Infection Cancer
2-Methoxy-1,6-dimethyl-5-vinyl-9,10-dihydrophenanthren-7-ol (Compound 1) is a 9,10-dihydrophenanthrene derivative. 2-Methoxy-1,6-dimethyl-5-vinyl-9,10-dihydrophenanthren-7-ol can be isolated from Juncus compressus. 2-Methoxy-1,6-dimethyl-5-vinyl-9,10-dihydrophenanthren-7-ol exhibits anticancer activity against cervical and ovarian cancers. 2-Methoxy-1,6-dimethyl-5-vinyl-9,10-dihydrophenanthren-7-ol can be used for HSV-2 virus research .

HY-129923R

*(R)-Omeprazole* sodium (Standard)**	HBV Reference Standards	Neurological Disease
(R)-Omeprazole (sodium) (Standard) is the analytical standard of (R)-Omeprazole (sodium). This product is intended for research and analytical applications. (R)-Omeprazole sodium is a gastric acid resistant compound with activity to inhibit gastric acid secretion. (R)-Omeprazole sodium is metabolized in vivo, and its metabolism is primarily affected by cytochrome P450 enzymes. The interaction between (R)-Omeprazole sodium and mannitol may affect its bioavailability in formulations. (R)-Omeprazole sodium exhibits reversible direct and metabolism-dependent inhibition of CYP2C19 .

HY-G0007S

Omeprazole sulfone-d3 omeprazole sulfone-d₃; omeprazole sulphone-d₃	Isotope-Labeled Compounds Drug Metabolite Cytochrome P450 Aryl Hydrocarbon Receptor	Infection Cancer
Omeprazole sulfone-d₃ is the deuterium labeled Omeprazole sulfone. Omeprazole sulfone (Omeprazole sulphone) is one of the major circulating metabolites of Omeprazole (HY-B0113) in vivo, and belongs to class 4 non-mutagenic impurities. Omeprazole sulfone does not bind to the aryl hydrocarbon receptor (AhR), nor does it induce the expression of CYP1A1 or CYP1A2. However, Omeprazole sulfone promotes the migration of gastric epithelial cells under basal conditions and reverses the inhibitory effect of Indomethacin (HY-14397) on cell migration. Omeprazole sulfone does not promote cell proliferation, nor does it upregulate COX-2 expression or activate signaling pathways such as ERK, P38 MAPK and PI3K. Omeprazole sulfone maintains basal ulcer healing under non-acid-dependent conditions and can be used in studies related to gastric ulcer repair .

HY-135111R

*4-Desmethoxy Omeprazole* (Standard)**	Reference Standards Drug Metabolite	Infection Metabolic Disease Cancer
4-Desmethoxy Omeprazole (Standard) is the analytical standard of 4-Desmethoxy Omeprazole. This product is intended for research and analytical applications. 4-Desmethoxy Omeprazole is the active metabolite of Omeprazole. Omeprazole, a proton pump inhibitor (PPI), is available for treatment of acid-related gastrointestinal disorders. Omeprazole shows competitive inhibition of CYP2C19 activity with a Ki of 2 to 6 μM . Omeprazole also inhibits growth of Gram-positive and Gram-negative bacteria .

HY-135111S

*4-Desmethoxy Omeprazole-d3*	Isotope-Labeled Compounds Drug Metabolite	Infection Metabolic Disease Cancer
4-Desmethoxy Omeprazole-d₃ is the deuterium labeled 4-Desmethoxy Omeprazole. 4-Desmethoxy Omeprazole is the active metabolite of Omeprazole. Omeprazole, a proton pump inhibitor (PPI), is available for treatment of acid-related gastrointestinal disorders. Omeprazole shows competitive inhibition of CYP2C19 activity with a K_iof 2 to 6 μM . Omeprazole also inhibits growth of Gram-positive and Gram-negative bacteria .

HY-138187

*4-Hydroxy omeprazole* sulfide**	Proton Pump	Metabolic Disease
4-Hydroxy omeprazole sulfide is a metabolite of the proton pump inhibitor Omeprazole (HY-B0113) .

HY-G0006R

Omeprazole sulfide (Standard) Ufiprazole (Standard)	Reference Standards Drug Metabolite	Others
Omeprazole sulfide (Standard) is the analytical standard of Omeprazole sulfide. This product is intended for research and analytical applications. Omeprazole sulfide is an Esomeprazole (HY-17021) precursor. Omeprazole sulfide can be converted to Esomeprazole by *Lysinibacillus* sp. B71. Esomeprazole can inhibit gastric H ⁺/ ⁺ ATP enzyme. Omeprazole sulfide is mainly used in gastroesophageal reflux disease, gastric ulcer and antibacterial research .

HY-141776S

Omeprazole sulfide-d3 Ufiprazole-d₃	Drug Metabolite	Others
Omeprazole sulfide-d₃ is the deuterium labeled Omeprazole sulfide. Omeprazole metabolite Omeprazole sulfide (Ufiprazole) is a metabolite of Omeprazole, which is a proton pump inhibitor.

HY-W335735

*N,N-dimethyl-N-((phenyl-d5)methyl)tetradecan-1-aminium bromide* Benzyldimethyltetradecylammonium Bromide	Isotope-Labeled Compounds	Others
N,N-dimethyl-N-((phenyl-dd₅)methyl)tetradecan-1-aminium bromide is the deuterium labeled N,N-dimethyl-N-((phenyl)methyl)tetradecan-1-aminium bromide .

HY-G0007S1

Omeprazole sulfone-13C,d3 omeprazole sulfone-¹³C,d₃; omeprazole sulphone-¹³C,d₃	Isotope-Labeled Compounds Drug Metabolite Cytochrome P450 Aryl Hydrocarbon Receptor	Others
Omeprazole sulfone- ¹³C,d₃ is the deuterium and ¹³C labeled Omeprazole sulfone. Omeprazole sulfone (Omeprazole sulphone) is one of the major circulating metabolites of Omeprazole (HY-B0113) in vivo, and belongs to class 4 non-mutagenic impurities. Omeprazole sulfone does not bind to the aryl hydrocarbon receptor (AhR), nor does it induce the expression of CYP1A1 or CYP1A2. However, Omeprazole sulfone promotes the migration of gastric epithelial cells under basal conditions and reverses the inhibitory effect of Indomethacin (HY-14397) on cell migration. Omeprazole sulfone does not promote cell proliferation, nor does it upregulate COX-2 expression or activate signaling pathways such as ERK, P38 MAPK and PI3K. Omeprazole sulfone maintains basal ulcer healing under non-acid-dependent conditions and can be used in studies related to gastric ulcer repair .

HY-B0113S4

Omeprazole-d3 sodium H 16868-d3 sodium	Isotope-Labeled Compounds Na+/K+ ATPase Interleukin Related Proton Pump Cytochrome P450 Bacterial Apoptosis Autophagy TNF Receptor Atg8/LC3	Infection Metabolic Disease Cancer
Omeprazole-d₃ sodium is deuterated labeled Omeprazole (HY-B0113). Omeprazole sodium (H 16868) is an orally active H ⁺,K ⁺-ATPase inhibitor and a proton pump inhibitor. Omeprazole sodium competitively inhibits CYP2C19, CYP3A4, and CYP2C9 activity. Omeprazole sodium inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole sodium inhibits pancreatic cancer cell proliferation, induces apoptosis, autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole sodium alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole sodium aslo has neuroprotective and antibacterial effects .

HY-138199S1

Omeprazole sulfone N-oxide-d3	Isotope-Labeled Compounds	Others
Omeprazole sulfone N-oxide-d₃ is the deuterium labeled Omeprazole sulfone N-Oxide .

Cat. No.	Product Name

HY-L203

Methylation Compound Library

342 compounds

Methylation is an epigenetic modification mechanism that involves adding methyl groups to molecules such as DNA and histones, which can alter gene expression without changing the DNA sequence. This process is catalyzed by enzymes such as DNA methyltransferases (DNMTs) and histone methyltransferases (HMTs), and can be reversed by demethylases. The balance of methylation and demethylation is crucial for maintaining cellular function and genomic stability. Abnormal regulation of methylation may lead to a variety of diseases, including cancer, neurological disorders, and developmental abnormalities. A deep understanding of the molecular mechanisms of methylation metabolism is essential for developing therapeutic strategies for diseases associated with methylation dysregulation.

MCE contains 342 compounds targeting methylation/demethylation enzymes, which is of significant value for studying the pathways of methylation metabolism and exploring their mechanisms of action in diseases.

Cat. No.	Product Name	Type

HY-Y0808

Dimethyl succinate

1 Publications Verification

Biochemical Assay Reagents

Dimethyl succinate is an orally active cell permeable succinate analogue. Dimethyl succinate can disrupt the TCA cycle by elevating intracellular succinate levels, leading to reduced protein synthesis and impairs myogenic differentiation. Dimethyl succinate can induce apoptosis. Dimethyl succinate can decrease maximal cellular respiration and reserve capacity. Dimethyl succinate can rescue synapse loss in AD. Dimethyl succinate can be used for the researches of metabolic and neurological disease ^[1][2].

HY-W003365

*(2-Chloro-4-pyridinyl)methanol*	Biochemical Assay Reagents
(2-chloro-4-pyridinyl)methanol is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

Cat. No.	Product Name	Target	Research Area

HY-P1108A

Astressin 2B TFA 1 Publications Verification	CRFR	Neurological Disease Inflammation/Immunology
Astressin 2B TFA is a blood-brain barrier-impermeable, highly selective CRFR2 antagonist (rCRFR2, IC₅₀=0.57 nM). Astressin 2B TFA blocks the protective effects mediated by CRFR2, thereby exacerbating indomethacin (HY-14397)-induced hemorrhagic intestinal injury in rats. Astressin 2B TFA reverses the protective effects of Urocortin 1 against intestinal hypermotility, bacterial invasion and upregulation of inflammatory mediators. Astressin 2B TFA also blocks the anxiogenic effect of Urocortin 2 and attenuates stress-induced anxiety-related behaviors. In the Clostridioides difficile toxin A (C. difficile toxin A)-mediated enteritis model, Astressin 2B TFA mimics the phenotype of CRFR2-deficient mice, significantly exacerbating intestinal epithelial damage, edema, neutrophil migration and the expression of multiple proinflammatory cytokines. Astressin 2B TFA is an important tool molecule for investigating the intestinal protective mechanisms of CRFR2 .

HY-P1108

Astressin 2B 1 Publications Verification	CRFR	Neurological Disease Inflammation/Immunology
Astressin 2B is a blood-brain barrier-impermeable, highly selective CRFR2 antagonist (rCRFR2, IC₅₀=0.57 nM). Astressin 2B blocks the protective effects mediated by CRFR2, thereby exacerbating indomethacin (HY-14397)-induced hemorrhagic intestinal injury in rats. Astressin 2B reverses the protective effects of Urocortin 1 against intestinal hypermotility, bacterial invasion and upregulation of inflammatory mediators. Astressin 2B also blocks the anxiogenic effect of Urocortin 2 and attenuates stress-induced anxiety-related behaviors. In the Clostridioides difficile toxin A (C. difficile toxin A)-mediated enteritis model, Astressin 2B mimics the phenotype of CRFR2-deficient mice, significantly exacerbating intestinal epithelial damage, edema, neutrophil migration and the expression of multiple proinflammatory cytokines. Astressin 2B is an important tool molecule for investigating the intestinal protective mechanisms of CRFR2 .

HY-P10143

MMP-2/MMP-9 Substrate Ac-Pro-Leu-Gly-[(S)-2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OEt	MMP	Others
MMP-2/MMP-9 Substrate (Ac-Pro-Leu-Gly-[(S)-2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OEt) is a synthetic chromogenic polypeptide substrate whose core structure mimics the cleavage sites of MMP-2 and MMP-9 (gelatinase A and B) in collagen. After being hydrolyzed by collagenase, MMP-2/MMP-9 Substrate reacts with 4,4'-dithiodipyridine or Ellman's Reagent via its thiol fragment to produce a product with ultraviolet absorption properties .

HY-P4308

*Z-Pro-Pro-aldehyde-dimethyl* acetal**	Prolyl Endopeptidase (PREP)	Neurological Disease
Z-Pro-Pro-aldehyde-dimethyl acetal is a potent inhibitor of prolyl endopeptidase (PREP), a cytoplasmic serine endoprotease (IC₅₀= 12 nM). Z-Pro-Pro-aldehyde-dimethyl acetal plays an important role in cognitive dysfunction in aging and neurodegenerative diseases including Alzheimer's disease .

HY-P2592

Ro 23-7014	Cholecystokinin Receptor	Others
Ro 23-7014 is an appetite suppressant. Ro 23-7014 is an analog of cholecystokinin (CCK-7) .

HY-125628

Kahalalide A	Endogenous Metabolite	Infection
Kahalalide A is an anti-mycobacterial compound with antimicrobial activity. Kahalalide A is derived from the marine mollusk Elysia rufescens. Kahalalide A has attracted extensive attention in natural product research due to its potential medicinal value .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-W009082

Methyl behenate 1 Publications Verification methyl docosanoate	Structural Classification Natural Products other families Classification of Application Fields Other Diseases Plants Disease Research Fields Source Classification	Biochemical Assay Reagents
Methyl behenate (Methyl docosanoate) is a fatty acid methyl ester, can be found in the plant Aspidopterys obcordata Lemsl. Methyl behenate can be used as a phase change material .

HY-W004286

Methyl laurate methyl dodecanoate	Structural Classification Natural Products Classification of Application Fields Labiatae Other Diseases Plants Medicago truncatula Gaertn. Disease Research Fields Source Classification	Environmental Pollutants Drug Derivative
Methyl laurate (Methyl dodecanoate) is a fatty acid methyl ester. Methyl laurate can serve as a raw material to produce sucrose monolaurate via transesterification with sucrose .

HY-W009082R

Methyl behenate (Standard) methyl docosanoate (Standard)	Structural Classification Natural Products other families Classification of Application Fields Other Diseases Plants Disease Research Fields Source Classification	Reference Standards Biochemical Assay Reagents
Methyl behenate (Standard) is the analytical standard of Methyl behenate (HY-W009082). This product is intended for research and analytical applications. Methyl behenate (Methyl docosanoate) is a fatty acid methyl ester. Methyl behenate can be isolated from the plant Aspidopterys obcordata Lemsl. Methyl behenate can be used as a phase change material .

HY-N13837

*2-Methoxy-1,6-dimethyl-5-vinyl-9,10-dihydrophenanthren-7-ol*	Natural Products Juncus effusus Linn. Juncaceae Phenols Plants Source Classification	Drug Derivative HSV
2-Methoxy-1,6-dimethyl-5-vinyl-9,10-dihydrophenanthren-7-ol (Compound 1) is a 9,10-dihydrophenanthrene derivative. 2-Methoxy-1,6-dimethyl-5-vinyl-9,10-dihydrophenanthren-7-ol can be isolated from Juncus compressus. 2-Methoxy-1,6-dimethyl-5-vinyl-9,10-dihydrophenanthren-7-ol exhibits anticancer activity against cervical and ovarian cancers. 2-Methoxy-1,6-dimethyl-5-vinyl-9,10-dihydrophenanthren-7-ol can be used for HSV-2 virus research .

HY-N8584

*(20S,25S)-20,25-Epoxy-25-methoxy-24,24-dimethyl-26,27-dinordammaran-3-one*	Triterpenes Terpenoids Plants Meliaceae Aglaia perviridis Hiern Source Classification	Others
(20S,25S)-20,25-Epoxy-25-methoxy-24,24-dimethyl-26,27-dinordammaran-3-one is a Triterpenoids product that can be isolated from the twigs of Aglaia perviridis .

HY-Y1314R

Dimethyl sulfone (Standard)	Structural Classification Natural Products Microorganisms Endogenous metabolite Source Classification	Drug Metabolite Reference Standards Endogenous Metabolite
Dimethyl sulfone (Standard) is the analytical standard of Dimethyl sulfone. This product is intended for research and analytical applications. Dimethyl sulfone (Methyl Sulfonyl Methane) is a metabolic product of endogenous methanethiol metabolism and intestinal bacterial metabolism. Dimethyl sulfone inhibits choriocapillary endothelial (CCE) cell proliferation, also has many biological effects, including antiinflammatory, antioxidant, and local anesthetic effects that could be neuroprotective .

HY-N9309

*2,6-Dimethyl-3-O-methyl-4-(2-methylbutyryl)phloroglucinol*	Phenols Myrtaceae Plants Eucalyptus robusta Smith Source Classification	Others
2,6-Dimethyl-3-O-methyl-4-(2-methylbutyryl)phloroglucinol is a Phenols product that can be isolated from the herbs of Eucalyptus robusta .

Species:	Human (7) E.coli (1)
Tag:	His (6) Strep (1) Tag Free (2) Myc (1) GST (1)
Source:	HEK293 (1) Sf9 insect cells (1) E. coli (7)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P701616

	PHF8 Protein, Human PHF8; Histone lysine demethylase PHF8; PHD finger protein 8; [histone H3]-dimethyl-L-lysine(36) demethylase PHF8; [histone H3]-dimethyl-L-lysine(9) demethylase PHF8	Human	E. coli
	The PHF8 protein is a histone lysine demethylase that plays a key role in cell cycle progression, rDNA transcription, and brain development. It selectively demethylates H3 'Lys-9' (H3K9Me1 and H3K9Me2), H3 'Lys-27' (H3K27Me2) and H4 'Lys-20' (H4K20Me1). PHF8 Protein, Human is the recombinant human-derived PHF8 protein, expressed by E. coli , with tag free.

HY-P701617

	PHF8 Protein, Human (His) PHF8; Histone lysine demethylase PHF8; PHD finger protein 8; [histone H3]-dimethyl-L-lysine(36) demethylase PHF8; [histone H3]-dimethyl-L-lysine(9) demethylase PHF8	Human	E. coli
	The PHF8 protein is a histone lysine demethylase that plays a key role in cell cycle progression, rDNA transcription, and brain development. It selectively demethylates H3 'Lys-9' (H3K9Me1 and H3K9Me2), H3 'Lys-27' (H3K27Me2) and H4 'Lys-20' (H4K20Me1). PHF8 Protein, Human (His) is the recombinant human-derived PHF8 protein, expressed by E. coli , with N-6*His labeled tag.

HY-P702176

	MDO Protein, Mycobacterium sp. (His) Methanol:N; N-dimethyl-4-nitrosoaniline oxidoreductase; MDO; Methanol dehydrogenase (nicotinoprotein); Methanol:NDMA oxidoreductase	Others	E. coli
	MDO (methanol dehydrogenase) is responsible for oxidizing methanol to produce formaldehyde. Although the in vivo electron acceptor remains unidentified, in vitro experiments indicate that N,N-dimethyl-4-nitrosaniline (NDMA) can serve as a suitable electron acceptor and is subsequently reduced to 4-(hydroxyamino) -N,N-Dimethylaniline. MDO Protein, Mycobacterium sp. (His) is the recombinant MDO protein, expressed by E. coli , with N-6*His labeled tag.

HY-P702948

	BCKDK Protein, Human (sf9, GST) Branched-chain alpha-ketoacid dehydrogenase kinase; BCKDH kinase; [3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase; mitochondrial	Human	Sf9 insect cells
	BCKDK Protein, Human (sf9, GST) is the recombinant human-derived BCKDK, expressed by Sf9 insect cells , with GST labeled tag.

HY-P70366

	MeCP2 Protein, Human (HEK293, His) 1 Publications Verification rHumethyl-CpG-binding protein 2/MECP2, His; methyl-CpG-binding protein 2; MECP2; MeCp-2 protein	Human	HEK293
	The MeCP2 protein is a chromosome binder that specifically binds to methylated DNA independent of flanking sequences. MeCP2 Protein, Human (HEK293, His) is the recombinant human-derived MeCP2 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P703609

	BCKDK Protein, Human Branched-chain alpha-ketoacid dehydrogenase kinase; [3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial; 2.7.11.4; BCKDK; Homo sapiens; Human; Kinase; Transferase; 2.7.11.1	Human	E. coli
	BCKDK Protein, Human is the recombinant human-derived BCKDK, expressed by E. coli, with tag free labeled tag.

HY-P703610

	BCKDK Protein, Human (His, Strep) Branched-chain alpha-ketoacid dehydrogenase kinase; [3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial; 2.7.11.4; BCKDK; Homo sapiens; Human; Kinase; Transferase; 2.7.11.1	Human	E. coli
	BCKDK Protein, Human (His, Strep) is the recombinant human-derived BCKDK, expressed by E. coli, with Strep, His labeled tag.

HY-P71457

	Dxr/DXP reductoisomerase Protein, E.coli (Myc, His) dxr; ispC; yaeM; b0173; JW01681-deoxy-D-xylulose 5-phosphate reductoisomerase; DXP reductoisomerase; EC 1.1.1.267; 1-deoxyxylulose-5-phosphate reductoisomerase; 2-C-methyl-D-erythritol 4-phosphate synthase	E.coli	E. coli
	Dxr/DXP Reductoisomerase is pivotal in isoprenoid biosynthesis, catalyzing the rearrangement and reduction of DXP to yield MEP. This step is critical in forming isoprenoid precursors, essential for cellular processes and metabolite synthesis. The enzyme's activity emphasizes its significance in regulating isoprenoid biosynthesis and cellular functions. Dxr/DXP reductoisomerase Protein, E.coli (Myc, His) is the recombinant E. coli-derived Dxr/DXP reductoisomerase protein, expressed by E. coli , with C-Myc, N-10*His labeled tag.

HY-P701888

	FTO Protein, Human (His) FTO; Alpha-ketoglutarate-dependent dioxygenase FTO; Fat mass and obesity-associated protein; U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO; U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO; mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO; m6A(m)-demethylase FTO; mRNA N(6)-methyladenosine demethylase FTO; tRNA N1-methyl adenine demethylase FTO	Human	E. coli
	FTO protein is an RNA demethylase that regulates fat mass, lipogenesis, and energy homeostasis by targeting N(6)-methyladenosine in mRNA. It also demethylates m6A in U6 snRNA and m6A(m) in 5'-cap, affecting mRNA stability. FTO Protein, Human (His) is the recombinant human-derived FTO protein, expressed by E. coli , with N-6*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-B0113S

Omeprazole-d3

1 Publications Verification

Omeprazole-d₃ (H 16868-d₃) is deuterium labeled Omeprazole. Omeprazole (H 16868) is an orally active H ⁺,K ⁺-ATPase inhibitor and a proton pump inhibitor. Omeprazole competitively inhibits CYP2C19, CYP3A4, and CYP2C9 activity. Omeprazole inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole inhibits pancreatic cancer cell proliferation, induces apoptosis, autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole aslo has neuroprotective and antibacterial effects .

HY-128454S

Dimethyl trisulfide-d6
Dimethyl trisulfide-d6 is deuterium labeled Dimethyl trisulfide (HY-128454). Dimethyl trisulfide is a cyanide antidote .

HY-126857S

*5-Hydroxy Omeprazole-d3*
5-Hydroxy Omeprazole-d₃ is deuterium labeled 5-Hydroxyomeprazole.

HY-138199S

Omeprazole sulfone N-oxide-13C,d3
Omeprazole sulfone N-oxide- ¹³C,d₃ is the deuterium and ¹³C labeled Omeprazole sulfone N-Oxide .

HY-W131494S

*(N)-Methyl* omeprazole-d3**
(N)-Methyl omeprazole-d₃ is the deuterium labeled (N)-Methyl omeprazole .

HY-B0113S2

Omeprazole sulfone (methoxy-d3)

Omeprazole sulfone (methoxy-d₃) is the deuterium labeled Omeprazole sulfone. Omeprazole sulfone (H 16868) is an orally active H ⁺,K ⁺-ATPase inhibitor and a proton pump inhibitor. Omeprazole sulfone competitively inhibits CYP2C19, CYP3A4, and CYP2C9 activity. Omeprazole sulfone inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole sulfone inhibits pancreatic cancer cell proliferation, induces apoptosis, autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole sulfone alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole sulfone aslo has neuroprotective and antibacterial effects .

HY-W777620

*1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone-13C,d3*
1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone- ¹³C,d₃ (rac-Cotinine- ¹³C,d₃) is the deuterium and ¹³C-labeled 1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone (HY-W588192).

HY-W701567

Dimethyl (S)-(4-(methyl-d3)-2-oxooctyl)phosphonate
Dimethyl (S)-(4-(methyl-d₃)-2-oxooctyl)phosphonate is the deuterium labeled Dimethyl (S)-(4-(methyl)-2-oxooctyl)phosphonate.

HY-G0007S

Omeprazole sulfone-d3

Omeprazole sulfone-d₃ is the deuterium labeled Omeprazole sulfone. Omeprazole sulfone (Omeprazole sulphone) is one of the major circulating metabolites of Omeprazole (HY-B0113) in vivo, and belongs to class 4 non-mutagenic impurities. Omeprazole sulfone does not bind to the aryl hydrocarbon receptor (AhR), nor does it induce the expression of CYP1A1 or CYP1A2. However, Omeprazole sulfone promotes the migration of gastric epithelial cells under basal conditions and reverses the inhibitory effect of Indomethacin (HY-14397) on cell migration. Omeprazole sulfone does not promote cell proliferation, nor does it upregulate COX-2 expression or activate signaling pathways such as ERK, P38 MAPK and PI3K. Omeprazole sulfone maintains basal ulcer healing under non-acid-dependent conditions and can be used in studies related to gastric ulcer repair .

HY-135111S

4-Desmethoxy Omeprazole-d3

4-Desmethoxy Omeprazole-d₃ is the deuterium labeled 4-Desmethoxy Omeprazole. 4-Desmethoxy Omeprazole is the active metabolite of Omeprazole. Omeprazole, a proton pump inhibitor (PPI), is available for treatment of acid-related gastrointestinal disorders. Omeprazole shows competitive inhibition of CYP2C19 activity with a K_iof 2 to 6 μM . Omeprazole also inhibits growth of Gram-positive and Gram-negative bacteria .

HY-141776S

Omeprazole sulfide-d3
Omeprazole sulfide-d₃ is the deuterium labeled Omeprazole sulfide. Omeprazole metabolite Omeprazole sulfide (Ufiprazole) is a metabolite of Omeprazole, which is a proton pump inhibitor.

HY-W335735

*N,N-dimethyl-N-((phenyl-d5)methyl)tetradecan-1-aminium bromide*
N,N-dimethyl-N-((phenyl-dd₅)methyl)tetradecan-1-aminium bromide is the deuterium labeled N,N-dimethyl-N-((phenyl)methyl)tetradecan-1-aminium bromide .

HY-G0007S1

Omeprazole sulfone-13C,d3

Omeprazole sulfone- ¹³C,d₃ is the deuterium and ¹³C labeled Omeprazole sulfone. Omeprazole sulfone (Omeprazole sulphone) is one of the major circulating metabolites of Omeprazole (HY-B0113) in vivo, and belongs to class 4 non-mutagenic impurities. Omeprazole sulfone does not bind to the aryl hydrocarbon receptor (AhR), nor does it induce the expression of CYP1A1 or CYP1A2. However, Omeprazole sulfone promotes the migration of gastric epithelial cells under basal conditions and reverses the inhibitory effect of Indomethacin (HY-14397) on cell migration. Omeprazole sulfone does not promote cell proliferation, nor does it upregulate COX-2 expression or activate signaling pathways such as ERK, P38 MAPK and PI3K. Omeprazole sulfone maintains basal ulcer healing under non-acid-dependent conditions and can be used in studies related to gastric ulcer repair .

HY-B0113S4

Omeprazole-d3 sodium

Omeprazole-d₃ sodium is deuterated labeled Omeprazole (HY-B0113). Omeprazole sodium (H 16868) is an orally active H ⁺,K ⁺-ATPase inhibitor and a proton pump inhibitor. Omeprazole sodium competitively inhibits CYP2C19, CYP3A4, and CYP2C9 activity. Omeprazole sodium inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole sodium inhibits pancreatic cancer cell proliferation, induces apoptosis, autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole sodium alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole sodium aslo has neuroprotective and antibacterial effects .

HY-138199S1

Omeprazole sulfone N-oxide-d3
Omeprazole sulfone N-oxide-d₃ is the deuterium labeled Omeprazole sulfone N-Oxide .

HY-W703575

*2,5-Dimethoxy-d6-4-methyl-benzene*
2,5-Dimethoxy-d₆-4-methyl-benzene (Methyl hydroquinone dimethyl ester-d₆-4-methyl-benzene) is the deuterium labeled 2,5-Dimethoxytoluene (HY-W100540).

HY-B0113S1

Omeprazole-d3-1

Omeprazole-d₃-1 is the deuterium labeled Omeprazole. Omeprazole-1 (H 16868) is an orally active H ⁺,K ⁺-ATPase inhibitor and a proton pump inhibitor. Omeprazole-1 competitively inhibits CYP2C19, CYP3A4, and CYP2C9 activity. Omeprazole-1 inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole-1 inhibits pancreatic cancer cell proliferation, induces apoptosis, autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole-1 alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole-1 aslo has neuroprotective and antibacterial effects .

HY-B0113S5

Omeprazole-d6

Omeprazole-d₆ (H 16868-d₆) is deuterium labeled Omeprazole. Omeprazole (H 16868) is an orally active H ⁺,K ⁺-ATPase inhibitor and a proton pump inhibitor. Omeprazole competitively inhibits CYP2C19, CYP3A4, and CYP2C9 activity. Omeprazole inhibits gastric acid secretion and can be used for acid-related gastrointestinal disorders. Omeprazole inhibits pancreatic cancer cell proliferation, induces apoptosis, autophagosome accumulation (elevated LC3-I and LC3-II levels), oxidative stress, and cytogenetic imbalance, modulates lysosomal transport, reduces inflammatory cytokines. Omeprazole alters small intestinal morphology and magnesium absorption, and induces gastric mucosa morphologic changes. Omeprazole aslo has neuroprotective and antibacterial effects .

HY-W721210

Methyl 3,4-bis(methoxy-d3)benzoate
Methyl 3,4-bis(methoxy-d₃)benzoate is the deuterium labeled Methyl 3,4-bis(methoxy)benzoate.

HY-W710737

*1-(Methoxy-d3)-4-(2-methyl-2-nitropropyl)benzene*
1-(Methoxy-d₃)-4-(2-methyl-2-nitropropyl)benzene is the deuterium labeled 1-(Methoxy)-4-(2-methyl-2-nitropropyl)benzene.

HY-W588192S

*1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone-13C2,d4*
1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone-13C2,d4 is the ¹³C and deuterium labeled isotope of 1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone (HY-W588192) .

HY-141731S

*2-(((3,5-Dimethylpyridin-2-yl)methyl)thio)-6-methoxy-1Hbenzo[d]imidazole (esomeprazole impurity)-d3*
4-Desmethoxy Omeprazole-d₃ sulfide is the deuterium labeled 4-Desmethoxy Omeprazole sulfide .

HY-W769685

*1-Hydroxy-2-(2-pyridinyl) risedronate-d4 hydrate*
1-Hydroxy-2-(2-pyridinyl) risedronate-d₄ hydrate is the deuterium labeled 1-Hydroxy-2-(2-pyridinyl) risedronate.

HY-W700730

*5-[(Dimethyl-amino)methyl]-2-furanmethanol-d6*
5-[(Dimethyl-amino)methyl]-2-furanmethanol-d₆ is the deuterium labeled (5-((dimethylamino)methyl)furan-2-yl)methanol (Ranitidine Impurity） (HY-Z2616).

HY-W699942

*3-(2-Hydroxy-2-(methyl)propyl) 5-methyl* 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate-d6**
3-(2-Hydroxy-2-(methyl-d₃)propyl-3,3,3-d₃) 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate is deuterated labeled 3-(2-Hydroxy-2-(methyl-)propyl-3,3,3-) 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.

HY-132403S

*4-(6-Nitro-3-pyridinyl)-piperazine-d4*
4-(6-Nitro-3-pyridinyl)-piperazine-2,2,6,6-d₄ is the deuterium labeled 4-(6-Nitro-3-pyridinyl)-piperazine-2,2,6,6 .

Host:	Mouse (6) Rabbit (24)
Reactivity:	Human (28) mouse (1) rat (1) Rat (22) Mouse (27) Monkey (2) Species independent (1)
Application:	WB IHC-P (1) IHC-P (18) ICC/IF (23) CHIP (4) IF-Tissue (1) IP (12) Cut&Tag (4) WB (28) ChIP (4) FC (4) Dot Blot (2) ELISA (10)
Isotype:	IgG,Kappa (5) IgG (18) IgG1 (3) IgG/Kappa (1) IgG2a (1)
Conjugation:	Non-conjugated (30)
Clonality:	Monoclonal (24) Recombinant (16)
Modification:	Methylated (23) Unmodified (4)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P86970

	*Mono-Methyl* Arginine (RGG) Antibody (YA6663)* Arginine (mono methyl) antibody; Mono-methyl Arginine (R*GG)	WB	Species independent
	Mono-Methyl Arginine (RGG) Antibody (YA6663) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Mono-Methyl Arginine (RGG).

HY-P81950

	MBD3 Antibody (YA1695) MBD3; methyl-CpG-binding domain protein 3; methyl-CpG-binding protein MBD3	WB, ICC/IF, FC, IP	Human, Mouse, Rat
	MBD3 Antibody (YA1695) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to MBD3.

HY-P87785

	*Histone H4 (Mono Methyl* Lys20) Antibody (YA7470)**	WB, IHC-P, ICC/IF, ELISA	Human, Mouse, Rat
	Histone H4 (Mono Methyl Lys20) Antibody (YA7470) is a Rabbit-derived and non-conjugated IgG, Kappa monoclonal antibody, targeting to Histone H4 (Mono Methyl Lys20).

HY-P87842

	*Histone H4 (Tri Methyl* Lys20) Antibody (YA7527)**	WB, IHC-P, ICC/IF, IP, ELISA, CHIP, Cut&Tag	Human, Mouse, Rat
	Histone H4 (Tri Methyl Lys20) Antibody (YA7527) is a Rabbit-derived and non-conjugated IgG, Kappa monoclonal antibody, targeting to Histone H4 (Tri Methyl Lys20).

HY-P80171

	*Histone H3 (di methyl* K9) Antibody (YA373)**	WB, ICC/IF, IHC-P	Human, Mouse, Rat
	Histone H3 (di methyl K9) Antibody (YA373) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Histone H3 (di methyl K9).

HY-P80172

	*Histone H3 (mono methyl* K18) Antibody (YA372)**	WB, ICC/IF, IHC-P	Human, Mouse
	Histone H3 (mono methyl K18) Antibody (YA372) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Histone H3 (mono methyl K18).

HY-P80173

	*Histone H3 (mono methyl* K36)Antibody (YA371)**	WB, ICC/IF	Human, Mouse
	Histone H3 (mono methyl K36)Antibody (YA371) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Histone H3 (mono methyl K36).

HY-P80174

	*Histone H3 (mono methyl* R2)Antibody (YA370)**	WB, ICC/IF	Human, Mouse
	Histone H3 (mono methyl R2)Antibody (YA370) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Histone H3 (mono methyl R2).

HY-P80181

	*Histone H4 (tri methyl* K20) Antibody (YA364)**	WB, IHC-P	Human, Mouse
	Histone H4 (tri methyl K20) Antibody (YA364) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Histone H4 (tri methyl K20).

HY-P87899

	*Histone H3 (Di Methyl* Lys27) Antibody (YA7584)**	WB, IHC-P, ICC/IF, IP, ELISA, CHIP, Cut&Tag	Human, Mouse, Rat
	Histone H3 (Di Methyl Lys27) Antibody (YA7584) is a Rabbit-derived and non-conjugated IgG, Kappa monoclonal antibody, targeting to Histone H3 (Di Methyl Lys27).

HY-P87915

	*Histone H3 (Mono Methyl* Lys4) Antibody (YA7600)**	WB, IHC-P, ICC/IF, IP, ELISA, CHIP, Cut&Tag	Human, Mouse, Rat
	Histone H3 (Mono Methyl Lys4) Antibody (YA7600) is a Rabbit-derived and non-conjugated IgG, Kappa monoclonal antibody, targeting to Histone H3 (Mono Methyl Lys4).

HY-P87930

	*Histone H3 (Tri Methyl* Lys4) Antibody (YA7615)**	WB, IHC-P, ICC/IF, IP, ELISA, CHIP, Cut&Tag	Human, Mouse, Rat
	Histone H3 (Tri Methyl Lys4) Antibody (YA7615) is a Rabbit-derived and non-conjugated IgG, Kappa monoclonal antibody, targeting to Histone H3 (Tri Methyl Lys4).

HY-P80165

	*Histone H2B (mono methyl* R79) Antibody (YA376)**	WB, ICC/IF, IHC-P	Human, Mouse
	Histone H2B (mono methyl R79) Antibody (YA376) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Histone H2B (mono methyl R79).

HY-P80175

	*Histone H3 (mono+di+tri methyl* K79) Antibody (YA369)**	WB, IHC-P	Human, Mouse, Rat
	Histone H3 (mono+di+tri methyl K79) Antibody (YA369) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Histone H3 (mono+di+tri methyl K79).

HY-P86957

	MBD1 Antibody (YA6650) CXXC 3 antibody; CXXC-type zinc finger protein 3 antibody; CXXC3 antibody; MBD 1 antibody; Mbd1 antibody; MBD1_HUMAN antibody; MECP1 COMPLEX antibody; methyl CpG binding domain protein 1 antibody; methyl CpG binding domain protein 1 isoform PCM1 antibody; methyl CpG binding protein MBD1 antibody; CXXC 3 antibody; CXXC-type zinc finger protein 3 antibody; CXXC3 antibody; MBD 1 antibody; Mbd1 antibody; MBD1_HUMAN antibody; MECP1 COMPLEX antibody; methyl CpG binding domain protein 1 antibody; methyl CpG binding domain protein 1 isoform PCM1 antibody; methyl CpG binding protein MBD1 antibody; methyl CpG binding protein splice variant 1 antibody; methyl CpG binding protein splice variant 2 antibody; methyl CpG binding protein splice variant 3 antibody; methyl CpG binding protein splice variant 4 antibody; methyl-CpG-binding domain protein 1 antibody; methyl-CpG-binding protein MBD1 antibody; PCM 1 antibody; PCM1 antibody; Protein containing methyl-CpG-binding domain 1 antibody; Regulator of fibroblast growth factor 2 (FGF 2) transcription antibody; RFT antibody; The regulator of fibroblast growth factor 2(FGF 2) transcription antibody;	WB, ICC/IF, FC	Mouse, Rat
	MBD1 Antibody (YA6650) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to MBD1.

HY-P810560

	DiMethyl-Histone H3 (Lys4) Antibody H3K27me3; H3 histone; HIST1H3A; Histone cluster 1; H3a	WB, ICC/IF, IHC-P, FC, Dot Blot	Human, Mouse, Rat
	DiMethyl-Histone H3 (Lys4) Antibody is a Rabbit-derived and non-conjugated IgG Polyclonal antibody, targeting to DiMethyl-Histone H3 (Lys4).

HY-P80643

	DiMethyl-Histone H3 Antibody (YA783) H3K27me2; H3 histone; HIST1H3A; Histone cluster 1; H3a	WB, ICC/IF, IP	Human, Mouse, Rat
	DiMethyl-Histone H3 Antibody (YA783) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to DiMethyl-Histone H3.

HY-P810565

	DiMethyl-Histone H3 (Lys27) Antibody (YA9831) H3K27me3; H3 histone; HIST1H3A; Histone cluster 1; H3a	WB, ICC/IF, ChIP	Human, Mouse, Rat
	DiMethyl-Histone H3 (Lys27) Antibody (YA9831) is a Rabbit-derived and non-conjugated IgG Recombinant, Monoclonal antibody, targeting to DiMethyl-Histone H3 (Lys27).

HY-P80643A

	DiMethyl-Histone H3 Antibody (YA783)(PBS only) H3K27me2; H3 histone; HIST1H3A; Histone cluster 1; H3a	WB, ICC/IF, IP	Human, Mouse, Rat
	DiMethyl-Histone H3 Antibody (YA783) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to DiMethyl-Histone H3.

HY-P810570

	DiMethyl-Histone H3 (Lys4) Antibody (YA9836) H3K27me3; H3 histone; HIST1H3A; Histone cluster 1; H3a	WB, ICC/IF, ChIP, Dot Blot, IHC-P	Human, Mouse, Rat, Monkey
	DiMethyl-Histone H3 (Lys4) Antibody (YA9836) is a Rabbit-derived and non-conjugated IgG Recombinant, Monoclonal antibody, targeting to DiMethyl-Histone H3 (Lys4).

HY-P86190

	MECP2 Antibody (YA5882) methyl-CpG-binding protein 2; MeCp-2 protein; MeCp2;	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	MECP2 Antibody (YA5882) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to MECP2.

HY-P810471

	BCKDK Antibody BCKDK, Branched Chain Keto Acid Dehydrogenase Kinase, [3-methyl-2-Oxobutanoate Dehydrogenase [Lipoamide]] Kinase, Mitochondrial, Branched-Chain Alpha-Ketoacid Dehydrogenase Kinase, BCKDH Kinase, EC 2.7.11.4, BCKDHKIN, BDK, 3-methyl-2-Oxobutanoate Dehydrogenase [Lipoamide] Kinase, Mitochondrial, Branched Chain Alpha-Ketoacid Dehydrogenase Kinase, Branched Chain Ketoacid Dehydrogenase Kinase, BCKD-Kinase, EC 2.7.11.1, EC 2.7.11, BCKDKD	WB IHC-P	Human, mouse, rat
	BCKDK Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to BCKDK.

HY-P87443A

	NR3B/GRIN3B Antibody (YA7131)(PBS only) GluN3B, N-methyl-D-aspartate receptor subtype 3B, NMDAR3B, NR3B, GRIN3B	FC, ELISA	Human
	NR3B/GRIN3B Antibody (YA7131) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to NR3B/GRIN3B.

HY-P87363

	*Histone H3 (mono+di+tri methyl* K79) Antibody (YA7046)** H3 histone family member E pseudogene antibody; H3 histone family, member A antibody; H3/A antibody; H31_HUMAN antibody; H3F3 antibody; H3FA antibody; Hist1h3a antibody; HIST1H3B antibody; HIST1H3C antibody; HIST1H3D antibody	WB, IHC-P, ICC/IF, ChIP	Human, Mouse, Rat, Monkey
	Histone H3 (mono+di+tri methyl K79) Antibody (YA7046) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Histone H3 (mono+di+tri methyl K79).

HY-P80176

	*Histone H3 (tri methyl* K9) Antibody (YA734)** H3K9me3; H3 histone family member E pseudogene; H3 histone family, memberA; H3/A; H31_HUMAN; H3F3; H3FA; Hist1h3a; HIST1H3B; HIST1H3C; HIST1H3D; HIST1H3E; HIST1H3F; HIST1H3G; HIST1H3H; HIST1H3I; HIST1H3J; HIST3H3; histone 1, H3a; Histone cluster 1, H3a; Histone H3 3 pseudogene; Histone H3.1; Histone H3/a; Histone H3/b; Histone H3/c; Histone H3/d; Histone H3/f; Histone H3/h; Histone H3/i; Histone H3/j; Histone H3/k; HistoneH3/l; H3K9me2; HistoneH3(trimethylK9)	WB, IHC-P, ICC/IF, IF-Tissue	Human, Mouse, Rat
	Histone H3 (tri methyl K9) Antibody (YA734) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Histone H3 (tri methyl K9).

HY-P86113

	*Histone H3 (Di Methyl* Lys4) Antibody (YA5805)** H3K4ME2; HIST1H3A; H3FA; HIST1H3B; H3FL; HIST1H3C; H3FC; HIST1H3D; H3FB; HIST1H3E; H3FD; HIST1H3F; H3FI; HIST1H3G; H3FH; HIST1H3H; H3FK; HIST1H3I; H3FF; HIST1H3J; H3FJ; Histone H3.1; Histone H3.1; Histone H3.2; Histone H3/m; Histone H3/o; H3F3A; H3.3A; H3F3; PP781; H3F3B; H3.3B; Histone H3.3; H3F3C; Histone H3.3C; Histone H3.5	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	Histone H3 (Di Methyl Lys4) Antibody (YA5805) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Histone H3 (Di Methyl Lys4).

HY-P85671

	*Histone H3 (Tri Methyl* Lys36) Antibody (YA5363)** H3K36ME3; HIST1H3A; H3FA; HIST1H3B; H3FL; HIST1H3C; H3FC; HIST1H3D; H3FB; HIST1H3E; H3FD; HIST1H3F; H3FI; HIST1H3G; H3FH; HIST1H3H; H3FK; HIST1H3I; H3FF; HIST1H3J; H3FJ; Histone H3.1; Histone H3/a; Histone H3/b; Histone H3/c; Histone H3/d; Histone H3/f; Histone H3/h; Histone H3/i; Histone H3/j; Histone H3/k; Histone H3/l; HIST2H3A; HIST2H3C; H3F2; H3FM; HIST2H3D; Histone H3.2; Histone H3/m; Histone H3/o; H3F3A; H3.3A; H3F3; PP781; H3F3B; H3.3B; Histone H3.3	WB, IP	Human, Mouse, Rat
	Histone H3 (Tri Methyl Lys36) Antibody (YA5363) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to Histone H3 (Tri Methyl Lys36).

HY-P86148

	*Histone H3 (Di Methyl* Lys9) Antibody (YA5840)** H3K9ME2; HIST1H3A; H3FA; HIST1H3B; H3FL; HIST1H3C; H3FC; HIST1H3D; H3FB; HIST1H3E; H3FD; HIST1H3F; H3FI; HIST1H3G; H3FH; HIST1H3H; H3FK; HIST1H3I; H3FF; HIST1H3J; H3FJ; Histone H3.1; Histone H3/a; Histone H3/b; Histone H3/c; Histone H3/d; Histone H3/f; Histone H3/h; Histone H3/i; Histone H3/j; Histone H3/k; Histone H3/l; HIST2H3A; HIST2H3C; H3F2; H3FM; HIST2H3D; Histone H3.2; Histone H3/m; Histone H3/o; H3F3A; H3.3A; H3F3; PP781; H3F3B; H3.3B; Histone H3.3	WB, IHC-P, ICC/IF, IP, ChIP, ELISA	Human, Mouse, Rat
	Histone H3 (Di Methyl Lys9) Antibody (YA5840) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Histone H3 (Di Methyl Lys9).

HY-P85670

	*Histone H3 (Di Methyl* Lys79) Antibody (YA5362)** H3K79ME2; HIST1H3A; H3FA; HIST1H3B; H3FL; HIST1H3C; H3FC; HIST1H3D; H3FB; HIST1H3E; H3FD; HIST1H3F; H3FI; HIST1H3G; H3FH; HIST1H3H; H3FK; HIST1H3I; H3FF; HIST1H3J; H3FJ; Histone H3.1; Histone H3/a; Histone H3/b; Histone H3/c; Histone H3/d; Histone H3/f; Histone H3/h; Histone H3/i; Histone H3/j; Histone H3/k; Histone H3/l; HIST2H3A; HIST2H3C; H3F2; H3FM; HIST2H3D; Histone H3.2; Histone H3/m; Histone H3/o; H3F3A; H3.3A; H3F3; PP781; H3F3B; H3.3B; Histone H3.3	WB	Human, Mouse, Rat
	Histone H3 (Di Methyl Lys79) Antibody (YA5362) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to Histone H3 (Di Methyl Lys79).

HY-P86071

	*Histone H3 (Tri Methyl* Lys36) Antibody (YA5763)** H3K36ME3; HIST1H3A; H3FA; HIST1H3B; H3FL; HIST1H3C; H3FC; HIST1H3D; H3FB; HIST1H3E; H3FD; HIST1H3F; H3FI; HIST1H3G; H3FH; HIST1H3H; H3FK; HIST1H3I; H3FF; HIST1H3J; H3FJ; Histone H3.1; Histone H3/a; Histone H3/b; Histone H3/c; Histone H3/d; Histone H3/f; Histone H3/h; Histone H3/i; Histone H3/j; Histone H3/k; Histone H3/l; HIST2H3A; HIST2H3C; H3F2; H3FM; HIST2H3D; Histone H3.2; Histone H3/m; Histone H3/o; H3F3A; H3.3A; H3F3; PP781; H3F3B; H3.3B; Histone H3.3	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	Histone H3 (Tri Methyl Lys36) Antibody (YA5763) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Histone H3 (Tri Methyl Lys36).

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name		Classification

HY-152376

*N6,N6-Dimethyl-3’-beta-C-methyl-adenosine*		Nucleoside Analogs Adenosine
N6,N6-Dimethyl-3’-beta-C-methyl- adenosine is an adenosine analogue. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. The popular products in this series are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277) .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

n-4-methoxy-3-5-dimethyl-2-pyridinyl-methyl-omeprazole-d3

Inhibitors & Agonists

Screening Libraries

Biochemical Assay Reagents

Peptides

NaturalProducts

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

Natural
Products